More than half of employees surveyed online said they had felt bullied or harassed in the workplace at the University Hospitals Birmingham trust.
One of the country’s largest NHS trusts has apologised for “unacceptable” behaviours and working practices identified in a new organisational culture review.
The trust, which has around 22,000 employees, came under review by the Birmingham and Solihull Integrated Care Board , after a junior doctor, Dr Vaishnavi Kumar, took her own life in June 2022. “Whilst staff have positive experiences within their site or team, staff experience in general, including physical, psychological, sexual safety, and wellbeing, is not often perceived by staff as being top priority for the trust.
The review team also said many staff at the trust often felt unsupported, disrespected, and pushed beyond their capacity, creating a culture where some staff feel they are treated like a number on a spreadsheet. “Throughout this review, it was observed that the trust is making steps to respond to these challenges and beginning to provide new routes and approaches to create a more positive culture.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
University Hospitals Birmingham: Half of staff have felt bulliedSome staff at University Hospitals Birmingham say they feared complaining would only make things worse.
Lire la suite »
Tees, Esk and Wear Valleys NHS Trust admits failures over deathsChristie Harnett, 17, and another woman took their own lives at separate hospitals in Middlesbrough.
Lire la suite »
NHS trust issues apology after culture report highlights bullying concernsMore than half of employees surveyed online said they had felt bullied or harassed in the workplace at the University Hospitals Birmingham trust.
Lire la suite »
New breast cancer treatment not approved for NHS useThe health spending watchdog said the ‘the cost-effectiveness estimates were too high for it to be recommended for use in the NHS’.
Lire la suite »
New breast cancer treatment not approved for NHS useThe health spending watchdog said the ‘the cost-effectiveness estimates were too high for it to be recommended for use in the NHS’.
Lire la suite »